Inhibition of cancer cell migration with CuS@ mSiO₂-PEG nanoparticles by repressing MMP-2/MMP-9 expression

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Research

Background:

• Cancer metastasis is a critical factor in disease progression and treatment outcomes.
• Current nanoparticle (NP) therapies for metastasis often rely on drug combinations, with limited data on the direct effects of NPs themselves.
• Understanding the intrinsic therapeutic potential of NPs is crucial for developing novel anti-metastasis strategies.

Purpose of the Study:

• To evaluate the direct therapeutic effects of copper sulfide-silica-PEG (CuS@mSiO2-PEG) nanoparticles on cancer cell migration and metastasis.
• To investigate the underlying molecular mechanisms, including the role of matrix metalloproteinases (MMPs) and the SRC/FAK signaling pathway.
• To assess the in vivo efficacy of CuS@mSiO2-PEG NPs in a mouse model of cancer metastasis.

Main Methods:

• Utilized transwell migration assays to assess the effect of CuS@mSiO2-PEG NPs on HeLa cell migration.
• Analyzed the expression levels of matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9).
• Investigated the involvement of the non-receptor tyrosine kinase protein (SRC)/focal adhesion kinase (FAK) signaling pathway using inhibitors and in vivo/in vitro models.
• Confirmed therapeutic efficacy through long-term survival curve studies in a mouse model.

Main Results:

• CuS@mSiO2-PEG NPs significantly inhibited the migration of HeLa cells.
• The observed migration suppression was linked to the modulation of MMP-2 and MMP-9 levels.
• Evidence suggests the involvement of the SRC/FAK signaling pathway, although other regulatory mechanisms may also contribute.
• In vivo studies demonstrated that CuS@mSiO2-PEG NPs effectively reduced cancer cell metastasis and improved survival rates in mice.

Conclusions:

• CuS@mSiO2-PEG NPs possess direct anti-metastatic properties, independent of drug co-administration.
• The mechanism of action involves the regulation of key metastasis-associated proteins and signaling pathways.
• These findings establish the direct therapeutic potential of NPs in controlling cancer metastasis and enhancing patient survival, opening new avenues for cancer therapy.